Register information Patent

DE file number : 60 2011 029 423.7 (Status: pending/in force, Query started: May 28, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2011 029 423.7
96EP file numberEAKZ11 79 9035.8
86WO file numberWAKZPCT/US2011/041924
97EP publication numberEPN2588130
87WO publication numberWPN2011163648
54Designation/titleTIABGABE THERAPEUTISCHER MITTEL IN DAS ZNS
51IPC main classICM
(ICMV)		 A61K 38/47 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61P 25/00 (2006.01), A61P 25/28 (2006.01), A61K 9/19 (2006.01), A61K 9/00 (2006.01), A61K 38/46 (2006.01)
22DE application dateDATJun 25, 2011
96EP application dateEATJun 25, 2011
86WO application dateWATJun 25, 2011
43Date of first publicationOTDec 29, 2011
Date of publication of grantPETAug 17, 2016
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, 541-0045 Osaka, JP
72InventorINSHAHROKH, Zahra, WestonMA 02493, US; CALIAS, Pericles, MelroseMA 02176, US; MCCAULEY, Thomas, CambridgeMA 02141, US; POWELL, Jan., Concord MA 01742, US; PAN, Jing., Boxborough, MA 01719, US; PFEIFER, Richard., North Granby, CT 06060, US; CHARNAS, Lawrence., Natick, MA 01760, US; WRIGHT, Teresa Leah., Lexington, MA 02142, US
74RepresentativeVTRMüller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
Address for service Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161495268 P
Jun 9, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161435710 P
Jan 24, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
358857 P
Jun 25, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
387862 P
Sep 29, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161476210 P
Apr 15, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
360786 P
Jul 1, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161442115 P
Feb 11, 2011
Due dateFT
FG		Jun 30, 2025
Annual fee for the 15th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002588130
Searchable text: EP000002588130
Original document: EP000002588130B1
Searchable text: EP000002588130B1
Original document: WO002011163648
Searchable text: WO002011163648
43Date of first publicationEVTDec 29, 2011
Date of the first transfer into DPMAregisterEREGTJun 21, 2013
Date of the (most recent) update in DPMAregisterREGTJul 10, 2024
(Show all update days)(Hide all update days)
  • Jul 10, 2024; May 28, 2024; Jun 3, 2023; Mar 16, 2023; Mar 15, 2023; Feb 14, 2023; May 26, 2022; Jan 25, 2022; Jun 1, 2021; May 28, 2020; Aug 16, 2019; May 29, 2019; Jun 7, 2018; Aug 31, 2017; Jul 27, 2017; Jul 21, 2017; Jul 7, 2017; Feb 28, 2017; Jan 5, 2017; Dec 1, 2016; Sep 29, 2016; Aug 24, 2016; Aug 18, 2016; Aug 9, 2016; Aug 2, 2013
    • Historical data not available for this/these date(s)
  • Jun 21, 2013
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Dec 29, 2011  Details anzeigen
2 Procedure relating to EP application EPO 1st publication May 8, 2013  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Jun 20, 2013 Jun 20, 2013 Details anzeigen
4 Change of classification Change of IPC main class Dec 10, 2013  Details anzeigen
5 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Aug 17, 2016  Details anzeigen
6 Publications Publication by DPMA of mention regarding EP patent grant Sep 29, 2016 Sep 29, 2016 Details anzeigen
7 New applicant/owner details New applicant/owner details Nov 30, 2016 Jan 5, 2017 Details anzeigen
8 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision May 18, 2017 Aug 31, 2017 Details anzeigen
9 New applicant/owner details New applicant/owner details Feb 13, 2023 Mar 23, 2023 Details anzeigen
10 New applicant/owner details New applicant/owner details Mar 15, 2023  Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTDec 29, 2011
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTMay 8, 2013
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTJun 20, 2013
Issue numberHN25
YearPJ2013
Publication dateVTJun 20, 2013
Type of publicationPARTBibliographic data
View procedures Change of classification (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTChange of classification
Legal/procedural statusVSTChange of IPC main class
Date of legal/procedural statusVSTTDec 10, 2013
51IPC main classICM
(ICMV)		 A61K 38/47 (2006.01)
51Previous IPC main classICMF
(ICMVF)		 A61K 38/46 (2006.01)
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTAug 17, 2016
View procedures Publications (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTSep 29, 2016
Issue numberHN39
YearPJ2016
Publication dateVTSep 29, 2016
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTNov 30, 2016
Issue numberHN1
YearPJ2017
Publication dateVTJan 5, 2017
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHShire Human Genetic Therapies, Inc., Lexington, Mass., US
71/73Previous applicant/ownerINHFShire Human Genetic Therapies, Inc., Cambridge, Mass., US
View procedures Procedure relating to EP application (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTMay 18, 2017
Issue numberHN35
YearPJ2017
Publication dateVTAug 31, 2017
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 9)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTFeb 13, 2023
Issue numberHN12
YearPJ2023
Publication dateVTMar 23, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHTakeda Pharmaceutical Co. Ltd., Osaka, JP
71/73Previous applicant/ownerINHFShire Human Genetic Therapies, Inc., Lexington, Mass., US
Date of update of the procedureREGTMar 15, 2023
View procedures New applicant/owner details (No.: 10)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTMar 15, 2023
71/73Previous applicant/ownerINHFTakeda Pharmaceutical Co. Ltd., Osaka, JP
Date of update of the procedureREGTMar 16, 2023